{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:47:43Z","timestamp":1793134063812,"version":"4.5.0"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,3,28]]},"DOI":"10.18632\/oncotarget.15592","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T16:33:37Z","timestamp":1487781217000},"page":"21472-21482","source":"Crossref","is-referenced-by-count":18,"title":["Critically short telomeres and toxicity of chemotherapy in early breast cancer"],"prefix":"10.18632","volume":"8","author":[{"given":"Miguel","family":"Quintela-Fandino","sequence":"first","affiliation":[{"name":"Breast Cancer Clinical Research Unit, CNIO-Spanish National Cancer Research Center, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Soberon","sequence":"additional","affiliation":[{"name":"Telomeres and Telomerase Group, Molecular Oncology Programme, CNIO-Spanish National Cancer Research Center, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lluch","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Manso","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Calvo","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital de Montepr\u00edncipe, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cortes","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Vall d\u00b4Hebron, Barcelona, Spain"},{"name":"Medical Oncology Department, Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Moreno-Ant\u00f3n","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Gil-Gil","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Martinez-J\u00e1nez","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Ram\u00f3n y Cajal, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gonzalez-Martin","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, MD Anderson Cancer Center, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarna","family":"Adrover","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital General de Albacete, Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"de Andres","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Lozano Blesa, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Vi\u00f1as","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Institut Catala d'Oncologia-Hospital Dr. Josep Trueta, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Llombart-Cussac","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Arnau de Vilanova, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Alba","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Cl\u00ednico Universitario Virgen de la Victoria, M\u00e1laga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Mouron","sequence":"additional","affiliation":[{"name":"Breast Cancer Clinical Research Unit, CNIO-Spanish National Cancer Research Center, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Guerra","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Bermejo","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Clinico Universitario, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Zamora","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Vall d\u00b4Hebron, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Angel","family":"Garc\u00eda-Saenz","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Pernas Simon","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Institut Catala d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Carrasco","sequence":"additional","affiliation":[{"name":"GEICAM, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Escudero","sequence":"additional","affiliation":[{"name":"GEICAM, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Campo","sequence":"additional","affiliation":[{"name":"GEICAM, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Colomer","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario La Princesa, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Blasco","sequence":"additional","affiliation":[{"name":"Telomeres and Telomerase Group, Molecular Oncology Programme, CNIO-Spanish National Cancer Research Center, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.2007.11.6699","article-title":"Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840","volume":"26","author":"Winer","year":"2008","journal-title":"J Clin Oncol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0707056","article-title":"Weekly paclitaxel in the adjuvant treatment of breast cancer","volume":"358","author":"Davidson","year":"2008","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nchembio.2007.38","article-title":"Telomere length, stem cells and aging","volume":"3","author":"Blasco","year":"2007","journal-title":"Nature chemical biology"},{"key":"4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg3246","article-title":"The telomere syndromes","volume":"13","author":"Blackburn","year":"2012","journal-title":"Nat Rev Genet"},{"key":"5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ctrv.2015.11.009","article-title":"Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force","volume":"43","author":"Brain","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1517\/17425255.2015.1037277","article-title":"Effect of age on drug metabolism in women with breast cancer","volume":"11","author":"Lichtman","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Kroemer","year":"2013","journal-title":"Cell"},{"key":"8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrc2393","article-title":"Telomere dysfunction and tumour suppression: the senescence connection","volume":"8","author":"Chang","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","article-title":"Cellular senescence in cancer and aging","volume":"130","author":"Serrano","year":"2007","journal-title":"Cell"},{"key":"10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/bjc.2012.421","article-title":"Predicting 5-fluorouracil toxicity in colorectal cancer patients from peripheral blood cell telomere length: a multivariate analysis","volume":"107","author":"Sakoff","year":"2012","journal-title":"Br J Cancer"},{"key":"11","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.2013.53.2465","article-title":"Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity","volume":"32","author":"Brennan","year":"2014","journal-title":"J Clin Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.18632\/aging.100462","article-title":"Beyond average: potential for measurement of short telomeres","volume":"4","author":"Blasco","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0092-8674(01)00504-9","article-title":"The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability","volume":"107","author":"Greider","year":"2001","journal-title":"Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1073\/pnas.0609367104","article-title":"High-throughput telomere length quantification by FISH and its application to human population studies","volume":"104","author":"Blasco","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature09603","article-title":"Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice","volume":"469","author":"Depinho","year":"2011","journal-title":"Nature"},{"key":"16","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2015-08-667485","article-title":"Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia","volume":"127","author":"Blasco","year":"2016","journal-title":"Blood"},{"key":"17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.15252\/emmm.201404497","article-title":"Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damage","volume":"7","author":"Blasco","year":"2015","journal-title":"EMBO Mol Med"},{"key":"18","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol Treatment for Telomere Diseases","volume":"374","author":"Gochuico","year":"2016","journal-title":"N Engl J Med"},{"key":"19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ctrv.2015.10.010","article-title":"Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review","volume":"41","author":"Boven","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"20","article-title":"18F-fluoromisonidazole PET and activity of neoadjuvant nintedanib in early HER2-negative breast cancer: a window-of-opportunity randomized trial","author":"Llombart Cussac","year":"2016","journal-title":"Clin Cancer Res"},{"key":"21","first-page":"912","article-title":"Telomere length abnormalities in mammalian radiosensitive cells","volume":"61","author":"Slijepcevic","year":"2001","journal-title":"Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1470-2045(13)70586-2","article-title":"Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial","volume":"15","author":"Gaschler-Markefski","year":"2014","journal-title":"Lancet Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy","volume":"25","author":"Hortobagyi","year":"2007","journal-title":"J Clin Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline","volume":"34","author":"LaMonte","year":"2016","journal-title":"J Clin Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11912-015-0475-8","article-title":"Treatment of Breast Cancer in the Elderly","volume":"17","author":"Freedman","year":"2015","journal-title":"Curr Oncol Rep"},{"key":"26","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1158\/1055-9965.EPI-12-0657","article-title":"Association of leukocyte telomere length with colorectal cancer risk: nested case-control findings from the Shanghai Women's Health Study","volume":"21","author":"Zheng","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/1055-9965.EPI-06-0961","article-title":"Telomere length, cigarette smoking, and bladder cancer risk in men and women","volume":"16","author":"De Vivo","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/aje\/kws291","article-title":"Association of leukocyte telomere length with breast cancer risk: nested case-control findings from the Shanghai Women's Health Study","volume":"177","author":"Zheng","year":"2013","journal-title":"Am J Epidemiol"},{"key":"29","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/ijc.24105","article-title":"Telomere length, oxidative damage, antioxidants and breast cancer risk","volume":"124","author":"Santella","year":"2009","journal-title":"Int J Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/djg011","article-title":"Telomere dysfunction: a potential cancer predisposition factor","volume":"95","author":"Spitz","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"31","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/1055-9965.EPI-08-0998","article-title":"A prospective study of relative telomere length and postmenopausal breast cancer risk","volume":"18","author":"Hunter","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s10552-011-9778-8","article-title":"Telomere length in peripheral blood and breast cancer risk in a prospective case-cohort analysis: results from the Sister Study","volume":"22","author":"Taylor","year":"2011","journal-title":"Cancer Causes Control"},{"key":"33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10549-009-0440-z","article-title":"Telomere length in blood cells and breast cancer risk: investigations in two case-control studies","volume":"120","author":"McCann","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1186\/s12885-015-1860-2","article-title":"Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsy","volume":"15","author":"Gierach","year":"2015","journal-title":"BMC Cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/0008-5472.CAN-07-6497","article-title":"Breast cancer survival is associated with telomere length in peripheral blood cells","volume":"68","author":"Roos","year":"2008","journal-title":"Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.onc.1205061","article-title":"Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis","volume":"21","author":"Greider","year":"2002","journal-title":"Oncogene"},{"key":"37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/genes7020007","article-title":"Telomeres and Telomerase in Cardiovascular Diseases","author":"Wang","year":"2016","journal-title":"Genes (Basel)"},{"key":"38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/ggi.12772","article-title":"Changes of telomere status with aging: An update","volume":"16","author":"Takubo","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"39","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood-2008-09-178871","article-title":"Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells","volume":"114","author":"Young","year":"2009","journal-title":"Blood"},{"key":"40","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3324\/haematol.2015.129239","article-title":"Therapeutic effect of androgen therapy in a mouse model of aplastic anemia produced by short telomeres","volume":"100","author":"Blasco","year":"2015","journal-title":"Haematologica"},{"key":"41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3349\/ymj.2005.46.4.471","article-title":"Effect of long-term hormone therapy on telomere length in postmenopausal women","volume":"46","author":"Shim","year":"2005","journal-title":"Yonsei Med J"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:59:20Z","timestamp":1594832360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":41,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2017,3,28]]}},"alternative-id":["15592","28423524"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15592","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}